CoChat

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Open access
Kelley, Nathan, Jeltema, Devon, Duan, Yanhui, He, Yuan · 2019 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 172 of the 176 references it cites were found in a registry or an index.

Abstract

The NLRP3 inflammasome is a critical component of the innate immune system that mediates caspase-1 activation and the secretion of proinflammatory cytokines IL-1β/IL-18 in response to microbial infection and cellular damage. However, the aberrant activation of the NLRP3 inflammasome has been linked with several inflammatory disorders, which include cryopyrin-associated periodic syndromes, Alzheimer’s disease, diabetes, and atherosclerosis. The NLRP3 inflammasome is activated by diverse stimuli, and multiple molecular and cellular events, including ionic flux, mitochondrial dysfunction, and the production of reactive oxygen species, and lysosomal damage have been shown to trigger its activation. How NLRP3 responds to those signaling events and initiates the assembly of the NLRP3 inflammasome is not fully understood. In this review, we summarize our current understanding of the mechanisms of NLRP3 inflammasome activation by multiple signaling events, and its regulation by post-translational modifications and interacting partners of NLRP3.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms20133328

Cites

172 of 172 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A Two-Signal Model for NLRP3 Inflammasome Activation. The priming signal (signal 1, left) is provided by microbial components or endogenous cytokines, leading to the activation of the transcription factor NF-κB and subsequent upregulation of NLRP3 and pro-interleukin-1β (pro-IL-1β). Caspase-8 and FAS-mediated death domain protein (FADD), and NOD1/2 are involved in the priming step by regulating the NF-κB pathway. NLRP3 undergoes post-translational modifications that license its activation. The activation signal (signal 2, right) is provided by a variety of stimuli including extracellular ATP, pore-forming toxins, RNA viruses, and particulate matter. Multiple molecular or cellular events, including ionic flux, mitochondrial dysfunction and reactive oxygen species (ROS) generation, and lysosomal damage, have been shown to activate the NLRP3 inflammasome. BRCC3, BRCA1/BRCA2-containing complex subunit 3; IL-1R, IL-1β receptor; JNK1, JUN N-terminal kinase 1; PKD, protein kinase D; TLR, toll-like receptor; TNFR, tumor necrosis factor receptor.
Figure 1 A Two-Signal Model for NLRP3 Inflammasome Activation. The priming signal (signal 1, left) is provided by microbial components or endogenous cytokines, leading to the activation of the transcription factor NF-κB and subsequent upregulation of NLRP3 and pro-interleukin-1β (pro-IL-1β). Caspase-8 and FAS-mediated death domain protein (FADD), and NOD1/2 are involved in the priming step by regulating the NF-κB pathway. NLRP3 undergoes post-translational modifications that license its activation. The activation signal (signal 2, right) is provided by a variety of stimuli including extracellular ATP, pore-forming toxins, RNA viruses, and particulate matter. Multiple molecular or cellular events, including ionic flux, mitochondrial dysfunction and reactive oxygen species (ROS) generation, and lysosomal damage, have been shown to activate the NLRP3 inflammasome. BRCC3, BRCA1/BRCA2-containing complex subunit 3; IL-1R, IL-1β receptor; JNK1, JUN N-terminal kinase 1; PKD, protein kinase D; TLR, toll-like receptor; TNFR, tumor necrosis factor receptor.CC BY · PubMed Central
Figure 2 Mechanism of Activation for the Non-Canonical and Alternative NLRP3 Inflammasome Pathways. Non-canonical NLRP3 inflammasome activation (left) is induced by LPS internalization into the cytosol by transfection or infection. Caspase-11/4/5 induces pyroptosis through the cleavage of GSDMD. This process also activates pannexin-1 through caspase-11 to release ATP and induce K+ efflux, which drives NLRP3 inflammasome assembly and release of IL-1β. The alternative NLRP3 inflammasome (right) is activated in human monocytes in response to LPS and requires receptor-interacting serine/threonine-protein kinase 1 (RIPK1), FADD, and caspase-8 for its activation. This pathway is K+ efflux independent and does not induce pyroptosis.
Figure 2 Mechanism of Activation for the Non-Canonical and Alternative NLRP3 Inflammasome Pathways. Non-canonical NLRP3 inflammasome activation (left) is induced by LPS internalization into the cytosol by transfection or infection. Caspase-11/4/5 induces pyroptosis through the cleavage of GSDMD. This process also activates pannexin-1 through caspase-11 to release ATP and induce K+ efflux, which drives NLRP3 inflammasome assembly and release of IL-1β. The alternative NLRP3 inflammasome (right) is activated in human monocytes in response to LPS and requires receptor-interacting serine/threonine-protein kinase 1 (RIPK1), FADD, and caspase-8 for its activation. This pathway is K+ efflux independent and does not induce pyroptosis.CC BY · PubMed Central
Figure 3 Post-translational Modifications and Regulators of NLRP3. NLRP3 is regulated via phosphorylation (P), ubiquitination (Ub), sumolyation (S), and s-nitrosylation (SN) through post-translational modifications. Post-translational modifications that positively affect NLRP3 activation are listed on the left and those that negatively act on NLRP3 to inhibit its activation are listed in the middle. Interacting partners of NLRP3 are listed on the right. ARIH2, ariadne homolog 2; BRCC3, BRCA1/BRCA2-containing complex subunit 3; FBX12, F-box/LRR-repeat protein 2; FBXO3, F-box only protein 3; JNK1, JUN N-terminal kinase 1; MAPL, mitochondrial-anchored protein ligase; MARCH7, membrane-associated RING finger protein 7; NO, nitric oxide; PKA, protein kinase A; PKD, protein kinase D; PP2A, phosphatase 2A; PTPN22, protein tyrosine phosphatase non-receptor 22; SENP6/7, sentrin/SUMO-specific proteases. GBP5, guanylate-binding protein 5; Hsp90, heat-shock protein 90; MARK4, microtubule-affinity regulating kinase 4; MIF, macrophage migration inhibitory factor; NEK7, NIMA-related kinase 7; PKR, double-stranded RNA-dependent protein kinase; STG1, suppressor of the G2 allele of skp1; TXNIP, thioredoxin-interacting protein.
Figure 3 Post-translational Modifications and Regulators of NLRP3. NLRP3 is regulated via phosphorylation (P), ubiquitination (Ub), sumolyation (S), and s-nitrosylation (SN) through post-translational modifications. Post-translational modifications that positively affect NLRP3 activation are listed on the left and those that negatively act on NLRP3 to inhibit its activation are listed in the middle. Interacting partners of NLRP3 are listed on the right. ARIH2, ariadne homolog 2; BRCC3, BRCA1/BRCA2-containing complex subunit 3; FBX12, F-box/LRR-repeat protein 2; FBXO3, F-box only protein 3; JNK1, JUN N-terminal kinase 1; MAPL, mitochondrial-anchored protein ligase; MARCH7, membrane-associated RING finger protein 7; NO, nitric oxide; PKA, protein kinase A; PKD, protein kinase D; PP2A, phosphatase 2A; PTPN22, protein tyrosine phosphatase non-receptor 22; SENP6/7, sentrin/SUMO-specific proteases. GBP5, guanylate-binding protein 5; Hsp90, heat-shock protein 90; MARK4, microtubule-affinity regulating kinase 4; MIF, macrophage migration inhibitory factor; NEK7, NIMA-related kinase 7; PKR, double-stranded RNA-dependent protein kinase; STG1, suppressor of the G2 allele of skp1; TXNIP, thioredoxin-interacting protein.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 1

  1. Kang, 2013, Toll-Like Receptor Signaling Licenses IRAK1 For Rapid Activation Of The NLRP3 Inflammasome, J. Immunol. Baltim. Md 1950, 191, 3995

Cited by

See all 3,539

Metadata

Authors
Kelley, N., Jeltema, D., Duan, Y., & He, Y.
Affiliations
Wayne State University (US)
Corresponding author
He, Yuan
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2019-07-06
Volume
20
Issue
13
Pages
3328
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2954782052
Cited by
3,539
References
176
Citations by year
2026: 466 · 2025: 573 · 2024: 631 · 2023: 687 · 2022: 563 · 2021: 383 · 2020: 220 · 2019: 12
FWCI
25.94
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Wayne State University
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (K22AI120988)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
NLRP3 inflammasome, inflammasome activation, caspase-1, IL-1β, IL-18, innate immunity, cryopyrin-associated periodic syndromes, Alzheimer's disease, diabetes mellitus, atherosclerosis, ion flux, mitochondrial dysfunction, reactive oxygen species, lysosomal damage, post-translational modification, inflammasome regulation
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Humans, Mitochondria, Models, Biological, Protein Processing, Post-Translational, Reactive Oxygen Species, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.